Apr
19
2021
Lyndra’s ultralong-acting pill shows promise in schizophrenia phase 2, teeing up pivotal trial – FierceBiotech
Lyndra’s ultralong-acting pill shows promise in schizophrenia phase 2, teeing up pivotal trial FierceBiotech